Iris Francesconi | Interim Head, Investor Relations |
Christopher Posner | President, CEO & Director |
Thomas Reilly | CFO |
Joana Goncalves | Chief Medical Officer |
Joseph Stringer | Needham & Company |
Nicholas Rubino | Stifel, Nicolaus & Company |
Sumant Kulkarni | Canaccord Genuity |
Chi Zhang | Bank of America Merrill Lynch |
Daniel Wolle | JPMorgan Chase & Co. |
David Amsellem | Piper Sandler & Co. |
Kambiz Yazdi | Jefferies |
Good afternoon. My name is Andrew, and I will be your conference facilitator. I would like to welcome everyone to the Cara Therapeutics Fourth Quarter 2021 Financial Results and Update Conference Call. All lines have been placed on mute to avoid any background noise. After the speakers' remarks, there will be a question-and-answer session.